Profile
Ryan V.
Hartwell is the founder of BirchBioMed, Inc. Prior to that, he worked as the Chief Scientific Officer and Chief Science Officer at Mind Cure Health, Inc. He holds a doctorate degree from the University of British Columbia and an undergraduate degree from the University of Ottawa.
Ryan V. Hartwell active positions
| Companies | Position | Start |
|---|---|---|
BirchBioMed, Inc.
 BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology BirchBioMed, Inc. operates as a clinical-stage biomedical company. It focuses on the clinical evaluation, development, and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company was founded by Mark S. Miller, Ryan V. Hartwell and Susan M. Elliott and is headquartered in King City, Canada. | Founder | - |
Former positions of Ryan V. Hartwell
| Companies | Position | End |
|---|---|---|
| LNG ENERGY GROUP CORP. | Chief Tech/Sci/R&D Officer | 2021-06-03 |
| LNG ENERGY GROUP CORP. | Chief Tech/Sci/R&D Officer | - |
Training of Ryan V. Hartwell
| University of British Columbia | Doctorate Degree |
| University of Ottawa | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
BirchBioMed, Inc.
BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology BirchBioMed, Inc. operates as a clinical-stage biomedical company. It focuses on the clinical evaluation, development, and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company was founded by Mark S. Miller, Ryan V. Hartwell and Susan M. Elliott and is headquartered in King City, Canada. | Health Technology |
Mind Cure Health, Inc.
 Mind Cure Health, Inc. Pharmaceuticals: OtherHealth Technology Mind Cure Health, Inc. operates as a life sciences company to identify and develop products that enhance mental health and wellness. The firm focuses on developing digital therapeutics technology and researching psychedelic compounds to rapidly scale science-backed and evidence-based mental health therapy globally. Its software iSTYRM is designed to provide close to real-time data regarding patient care, procedures and protocols, and other resources for therapists, practitioners and patients with mental health concerns. The company was founded by Philip Tapley on March 6, 2020 and is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Ryan V. Hartwell
